Teresa López‐Fernández

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch et al. · European Heart Journal · 2022 · 2.8K citations · Full text

Medicine, Hematology, Oncology +17

2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines

José Luis Zamorano, Patrizio Lancellotti, Daniel Muñoz et al. · European Heart Journal · 2016 · 2.5K citations · Full text

Medicine, Oncology, Toxicology +17

Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

Alexander R. Lyon, Susan Dent, Susannah Stanway et al. · European Journal of Heart Failure · 2020 · 770 citations · Full text

Medicine, Cardiology, Oncology +16

Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement

Joerg Herrmann, Daniel J. Lenihan, Saro H. Armenian et al. · European Heart Journal · 2021 · 595 citations · Full text

Medicine, Cardiology, Oncology +16

2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)

Alexander R. Lyon, Teresa López‐Fernández, Liam S. Couch et al. · European Heart Journal - Cardiovascular Imaging · 2022 · 491 citations · Full text

Medicine, Hematology, Oncology +17